Sugar Land Veterinary Imaging
1515 Lake Pointe Parkway
Lake Pointe Town Center
Sugar Land, TX 77478
281.491.7800
281.491.7803 Fax
Employment Opportunities
Veterinary Internist needed. Click here or within the Employment Section for more details
Oncology
What is the Oncology Section at SLVS?
We are a comprehensive and progressive veterinary cancer referral center specializing in the diagnosis, management, and treatment of cancer.
What services are offered?
The Sugar Land Veterinary Oncology Section is a combination of several different departments working together under one roof to provide comprehensive care for our cancer patients. The Oncology Section is headed by Dr. Andrew Novosad. He coordinates the diagnosis and clinical staging of our cancer patients through cytology, histopathology, and diagnostic imaging (radiographs, ultrasound, CT Scan, endoscopy) to determine the extent of disease and to assist in formulating a treatment plan specifically designed for each patient. Treatment plans vary depending upon the tumor type and extent of disease, but treatment options available include surgery, chemotherapy, radiation therapy, and pain management.
My pet was recently diagnosed with cancer. Why do I need to see a board-certified veterinary oncologist?
Hearing that your beloved pet has cancer can be a devastating experience. We understand what an emotional and confusing time this can be for most pet owners. Our goal is to educate owners as to what the latest treatment options are so that an informed decision regarding treatment can be made. During the initial consultation, Dr. Novosad will review your pet’s medical history and perform a thorough physical exam. Based on these findings, additional testing and treatment options will be discussed.
PALLADIA is Now Available!
Oncology Service Offers Pfizer's New Canine Cancer Therapy
Sugar Land Veterinary Specialists – Oncology Section is now able to offer PALLADIA, the new cancer fighting drug from Pfizer, to our patients. On June 3rd, the FDA approved the first canine cancer therapy, as Pfizer Animal Health received approval for PALLADIA. PALLADIA (toceranib phosphate) was developed to treat canine mast cell tumors (MCT). PALLADIA is an oral therapy indicated to treat Patnaik grade II or III MCT with or without regional lymph node involvement. If your pet has been diagnosed with canine mast cell tumr, ask your primary care veterinarian to contact Andrew Novosad, DVM, DACVIM, at 281-491-7800 to discuss this exciting new treatment option.
Helpful Cancer Links